MiNK Therapeutics will announce Q1 2025 financial results on May 15, followed by a conference call at 8:30 a.m. ET. MiNK Therapeutics, Inc. announced that it will release its first quarter 2025 ...
MiNK Therapeutics, Inc. announced its first-quarter 2025 financial results and highlighted significant progress in its development of allogeneic invariant natural killer T (iNKT) cell therapies. The ...
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Thank you for standing by. My name is Rochelle, and I will be your conference operator today. At this time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results